BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3214327)

  • 1. Cefoperazone in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Leehey DJ; Reid R; Chan AY; Ing TS
    Artif Organs; 1988 Dec; 12(6):482-3. PubMed ID: 3214327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis.
    Lui SF; Cheng AB; Leung CB; Wong KC; Li PK; Lai KN
    Am J Nephrol; 1994; 14(3):182-6. PubMed ID: 7977477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
    Fuiano G; Sepe V; Viscione M; Nani E; Conte G
    Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalexin for the oral treatment of CAPD peritonitis.
    Drew PJ; Casewell MW; Desai N; Houang ET; Simpson CN; Marsh FP
    J Antimicrob Chemother; 1984 Feb; 13(2):153-9. PubMed ID: 6368518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.
    Pérez-Fontán M; Rosales M; Fernández F; Moncalián J; Fernández-Rivera C; Alonso A; Valdés F
    Perit Dial Int; 1991; 11(3):233-6. PubMed ID: 1912018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program.
    Holley JL; Bernardini J; Johnston JR; Piraino B
    Am J Kidney Dis; 1990 Aug; 16(2):142-6. PubMed ID: 2382651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review.
    Wang Z; Li Z; Luo S; Yang Z; Xing Y; Pu C; Dong J
    J Int Med Res; 2021 Jun; 49(6):3000605211025367. PubMed ID: 34162261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urokinase for recurrent CAPD peritonitis.
    Pickering SJ; Bowley JA; Fleming SJ; Oppenheim BA; Ralston AJ; Sissons P; Ackrill P; Burnie J
    Lancet; 1987 May; 1(8544):1258-9. PubMed ID: 2884384
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of CAPD peritonitis with oral ciprofloxacin.
    Nephrol Dial Transplant; 1989; 4(8):759. PubMed ID: 2510089
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD).
    Ludlam HA; Barton I; White L; McMullin C; King A; Phillips I
    J Antimicrob Chemother; 1990 May; 25(5):843-51. PubMed ID: 2197264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial aggregation in relation to peritoneal dialysis.
    Reid G; Schwarz-Faulkner S; McGroarty JA; Bruce AW
    Perit Dial Int; 1990; 10(1):21-4. PubMed ID: 2085576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritonitis in patients on continuous ambulatory peritoneal dialysis. A changing scene.
    Grefberg N; Danielson BG; Nilsson P
    Scand J Infect Dis; 1984; 16(2):187-94. PubMed ID: 6740249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritonitis due to Staphylococcus sciuri in a patient on continuous ambulatory peritoneal dialysis.
    Wallet F; Stuit L; Boulanger E; Roussel-Delvallez M; Dequiedt P; Courcol RJ
    Scand J Infect Dis; 2000; 32(6):697-8. PubMed ID: 11200385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin use in peritoneal dialysis.
    Zimmerman SW; Johnson CA
    Perit Dial Int; 1989; 9(4):241-3. PubMed ID: 2488374
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
    Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory studies on coagulase-negative staphylococci from CAPD-associated peritonitis.
    Wilcox MH; Edwards R; Finch RG
    J Antimicrob Chemother; 1985 Mar; 15(3):297-303. PubMed ID: 3997705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiologic aspects of chronic ambulatory peritoneal dialysis.
    Vas SI
    Kidney Int; 1983 Jan; 23(1):83-92. PubMed ID: 6339790
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of peritonitis in CAPD with intraperitoneal rifampin.
    Paiva A; Cirugeda A; Bajo MA; Selgas R; Selgas R
    Perit Dial Int; 1998; 18(5):543-4. PubMed ID: 9848641
    [No Abstract]   [Full Text] [Related]  

  • 20. Vancomycin therapy for gram-positive peritonitis in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis H; Coucudis P; Peihaberis P; Jafer H; Jara F; Kartali S
    Adv Perit Dial; 1989; 5():128-9. PubMed ID: 2577394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.